Does estrogen therapy reduce coronary artery calcification in postmenopausal women?
John C Stevenson
Correspondence National Heart and Lung Institute, Imperial College London, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
Email j.stevenson@imperial.ac.uk
This article has no abstract so we have provided the first paragraph of the full text.
The loss of ovarian hormones at the menopause leads to an increased incidence of coronary heart disease (CHD), the leading cause of death for women in developed countries. Large population studies have shown an association between postmenopausal hormone replacement therapy (HRT) and reduction in cardiovascular disease.1
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
